Newsround

Selected reports edited by Janet Fricker ABVD less effective and more toxic in older patients =>Journal of Clinical Oncology In patients aged 60 years or older with Hodgkin lymphoma (HL), four cycles of ABVD is [more]

Time to act on trials

Number 52

1 January 2013 0

Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we [more]

Me and my cancer

Number 52

1 January 2013 0

Journalists who write about their own cancer journeys are able to convey important insights in a language that people understand – and are eager to read It is not surprising that a lot of journalists [more]

Mr Hodgkin’s disease

Volker Diehl cultured the cells that characterise Hodgkin’s disease when everyone else had failed. He has high hopes that molecular medicine will throw light on many questions that remain unanswered. But he stresses that it [more]

1 2 3
UA-77507851-1